Publications in collaboration with researchers from Universidad Complutense de Madrid (43)

2025

  1. Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk

    Revista Espanola de Cardiologia, Vol. 78, Núm. 5, pp. 416-424

  2. Cardiac electrical abnormalities in a mouse model of left ventricular non-compaction cardiomyopathy

    PLoS ONE, Vol. 20, Núm. 5 May

  3. Impact of lesion hemodynamic pattern and calcium morphology on the functional efficacy of coronary intravascular lithotripsy

    Cardiovascular Revascularization Medicine

  4. Perioperative/Periprocedural Antithrombotic Management in Oral Health Procedures. A Prospective Observational Study

    Dentistry Journal, Vol. 13, Núm. 5

  5. Spanish heart transplant registry. 36th official report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia

  6. Unraveling Comorbidities Contribution to Cardiac Diastolic Dysfunction and Heart Failure

    Circulation: Heart Failure, Vol. 18, Núm. 1

2024

  1. Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy

    Journal of the American Heart Association, Vol. 13, Núm. 21, pp. e036208

  2. Hypertrophic cardiomyopathy due to truncating variants in myosin binding protein C: A Spanish cohort

    Open Heart, Vol. 11, Núm. 2

  3. Impact of coronary calcium morphology on intravascular lithotripsy

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 10, pp. e656-e668

  4. Incidence and clinical impact of inappropriate periprocedural and perioperative management of antiplatelet therapy

    Medicina Clinica, Vol. 163, Núm. 7, pp. 336-343

  5. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial

    JAMA network open, Vol. 7, Núm. 3, pp. e240809

  6. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

    Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651

  7. Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties?

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 701-703

  8. Routine invasive strategy and frailty burden in non-ST-segment elevation acute myocardial infarction

    Journal of Geriatric Cardiology, Vol. 21, Núm. 10, pp. 954-961

2023

  1. Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment

    American Journal of Cardiology, Vol. 203, pp. 122-127

  2. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 8-15

  3. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  4. Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non-ST-Segment Elevation Acute Myocardial Infarction: A Randomized Clinical Trial

    JAMA Internal Medicine, Vol. 183, Núm. 5, pp. 407-415

  5. Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

    Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049

  6. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14